Drug Target Review

MARCH 3, 2025

Turning this tide, Professor Jens Christian Schwamborn, a cell biology expert at the University of Luxembourg and co-founder of OrganoTherapeutics , is leading a groundbreaking effort to transform our understanding and treatment of these debilitating diseases. .

Disease 52

Disease Treatment Therapies Cell Biology 52

Drug Target Review

SEPTEMBER 19, 2023

Pharmaceutical companies adapted the usage of organoids derived from specific patient derived tumours in cancer drug screening process for testing drug toxicities and efficacy. From 3D cell culture to organs-on-chips. Trends in Cell Biology. Reconstituting Organ-Level Lung Functions on a Chip. 2011;21(12):745-54.

Animal Testing 98

Animal Testing Clinical Trials Pharmaceutical Companies FDA 98

The Pharma Data

OCTOBER 19, 2020

a multinational pharmaceutical company, where he was the head of Research & Development and responsible for the R&D strategy (France). in Cell Biology from Utrecht University. Dr. Kraan joins AM-Pharma from Pierre Fabre S.A., Before Pierre Fabre, Dr. Kraan was head of R&D at Stallergenes Greer Ltd.

Trials 40

Trials Small Molecule Cell Biology Clinical Trials 40

Elrig

APRIL 29, 2024

Harini Srinivasan is a Principal Scientific Associate at Serna Bio with over 10 years of research experience in academic institutions, health care organizations and pharmaceutical companies. Driven by an interest in drug discovery Millie joined AstraZeneca after completion of her PhD at the end of 2020.

Bioinformatics 59

Bioinformatics Drugs Molecular Biology Cell Based Assays 59

Codon

APRIL 9, 2024

When Louis Miller, now Chief of Malaria Cell Biology at the NIH, attended a malaria conference in Shanghai in 2008, he asked: Who discovered artemisinin? Medical research groups were joined by pharmaceutical companies, chemical and spice factories, botany institutes, and insect science institutes. Nobody had an answer.

Drugs 135

Drugs Science Research Doctors 135

Alta Sciences

JANUARY 31, 2025

A non-profit organization, STC was founded in 1965 with 15 scientists from Montral-based pharmaceutical companies. Before joining Altasciences, Ria received a Bachelor of Science from McGill Universitys Department of Anatomy and Cell Biology in 1998, and became a Diplomate of the American Board of Toxicology in October 2016.

Cell Biology 52

Cell Biology Pharmaceutical Companies Clinical Research Government 52